Cargando…
The current status of COVID-19 vaccines. A scoping review
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new disease that has led to a worldwide pandemic, resulting in millions of deaths and a high economic burden. Here, we analyze the current status of preventive vaccines authorized by the European Medicines Agency (EMA) and the US Food...
Autores principales: | Rueda-Fernández, Manuel, Melguizo-Rodríguez, Lucía, Costela-Ruiz, Víctor J., González-Acedo, Anabel, Ramos-Torrecillas, Javier, Illescas-Montes, Rebeca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389839/ https://www.ncbi.nlm.nih.gov/pubmed/35995361 http://dx.doi.org/10.1016/j.drudis.2022.08.004 |
Ejemplares similares
-
High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
por: Xu, Tuan, et al.
Publicado: (2021) -
Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022) -
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021) -
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022) -
Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021)